Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klara Horackova

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuropsychiatric Disease and Treatment|June 26, 2020
Can Maternal Autoantibodies Play an Etiological Role in ASD Development?Iva Dudova, Klara Horackova, Michal Hrdlicka, et al.
International Journal of Molecular Sciences|December 9, 2023
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Klara Horackova, Marketa Janatova, Petra Kleiblova, et al.
Cancer Biomarkers : Section a of Disease Markers|April 12, 2024
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancerKlara Horackova, Michal Vocka, Sarka Lopatova, et al.
Frontiers in Psychiatry|March 3, 2020
The Onset of Diabetes During Transcranial Direct Current Stimulation Treatment of Anorexia Nervosa - A Case ReportTadeas Mares, Silvie Ceresnakova, Jakub Albrecht, et al.
Plos One|January 8, 2025
A retrospective single-center pilot study of the genetic background of the transplanted kidneyAnna Novotna, Klara Horackova, Jana Soukupova, et al.
Oncogene|September 5, 2024
PPM1D activity promotes cellular transformation by preventing senescence and cell deathMiroslav Stoyanov, Andra S Martinikova, Katerina Matejkova, et al.
Scientific Reports|July 13, 2024
A comprehensive analysis of germline predisposition to early-onset ovarian cancerKlara Horackova, Petra Zemankova, Petr Nehasil, et al.
Cancers|January 8, 2023
Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular CarcinomaKlara Horackova, Sona Frankova, Petra Zemankova, et al.
Cancer|May 8, 2024
Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk predictionMilena Hovhannisyan, Petra Zemankova, Petr Nehasil, et al.
Oncology Letters|May 8, 2023
Germline multigene panel testing of patients with endometrial cancerJan Kral, Sandra Jelinkova, Petra Zemankova, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuropsychiatric Disease and Treatment|June 26, 2020
Can Maternal Autoantibodies Play an Etiological Role in ASD Development?Iva Dudova, Klara Horackova, Michal Hrdlicka, et al.
International Journal of Molecular Sciences|December 9, 2023
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Klara Horackova, Marketa Janatova, Petra Kleiblova, et al.
Cancer Biomarkers : Section a of Disease Markers|April 12, 2024
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancerKlara Horackova, Michal Vocka, Sarka Lopatova, et al.
Frontiers in Psychiatry|March 3, 2020
The Onset of Diabetes During Transcranial Direct Current Stimulation Treatment of Anorexia Nervosa - A Case ReportTadeas Mares, Silvie Ceresnakova, Jakub Albrecht, et al.
Plos One|January 8, 2025
A retrospective single-center pilot study of the genetic background of the transplanted kidneyAnna Novotna, Klara Horackova, Jana Soukupova, et al.
Oncogene|September 5, 2024
PPM1D activity promotes cellular transformation by preventing senescence and cell deathMiroslav Stoyanov, Andra S Martinikova, Katerina Matejkova, et al.
Scientific Reports|July 13, 2024
A comprehensive analysis of germline predisposition to early-onset ovarian cancerKlara Horackova, Petra Zemankova, Petr Nehasil, et al.
Cancers|January 8, 2023
Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular CarcinomaKlara Horackova, Sona Frankova, Petra Zemankova, et al.
Cancer|May 8, 2024
Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk predictionMilena Hovhannisyan, Petra Zemankova, Petr Nehasil, et al.
Oncology Letters|May 8, 2023
Germline multigene panel testing of patients with endometrial cancerJan Kral, Sandra Jelinkova, Petra Zemankova, et al.
Pageof 2